Merative US L.P.

Merative US L.P., a for-profit healthcare data and analytics company based in Ann Arbor, Michigan, delivers licensed access to proprietary clinical decision-support databases and healthcare claims research datasets to federal agencies as a prime contractor on full-and-open procurements, with no set-aside certifications. The company operates as a parent entity with Micromedex LLC as a named subsidiary and competes predominantly through direct prime awards rather than subcontracting, though it does appear as a data-access subcontractor under larger research primes.

Merative's capability portfolio centers on three core product lines: the MarketScan Research Databases (de-identified healthcare claims data covering over 200 million covered lives from private insurers, employers, Medicare, and Medicaid); clinical decision-support tools including IBM Micromedex, Neofax, and Redbook pharmacy reference databases; and commercial data analytics platforms. Recent representative work includes a $2.71 million definitive contract from the Centers for Disease Control and Prevention (Pittsburgh) for MarketScan Databases (awarded September 2024, running through September 2027); a $3.005 million sole-source purchase order from the Department of Health and Human Services Office of the Assistant Secretary for Administration for commercial healthcare claims data and online analytical tools (awarded September 2022, running through September 2027); a $699,441 definitive contract from the Centers for Medicare and Medicaid Services for MarketScan Commercial Claims database access (awarded September 2023, running through September 2026); and a $545,958 purchase order from the Bureau of Economic Analysis for MarketScan Research Databases (awarded June 2026, running through June 2031). Smaller contracts include clinical database renewals — a $75,159 Redbook license from CDC Pittsburgh and a $40,505 Neofax subscription from the Defense Health Agency, both sole-source awards reflecting Merative's exclusive rights to these proprietary products.

Customer concentration aligns heavily with health research and policy agencies. The top five funding agencies account for 73% of recent awards by count and 94% by combined potential value. The Centers for Disease Control and Prevention (Pittsburgh) leads by dollar value ($4 million across four awards); the Office of the Assistant Secretary for Administration ($3 million across two awards) and the Bureau of Economic Analysis ($1.9 million across four awards) round out the top three. The Centers for Medicare and Medicaid Services shows the highest award count (10 awards) but carries the lowest per-award value ($1.3 million combined), reflecting transactional license renewals. The Department of Veterans Affairs, the Consumer Product Safety Commission, the Defense Health Agency, and the Indian Health Service round out the customer set. Seven awards (combined potential value $6.6 million) face ultimate completion in the next twenty-four months, presenting recompete exposure concentrated in MarketScan renewals and clinical database subscriptions.

Merative places work on three parent vehicles: the Research, Measurement, Assessment, Design, and Analysis 2 contract (7 task orders), the GSA Multiple Award Schedule (2 task orders), and the IT Schedule 70 (1 task order). The company appears as a subcontractor to larger research consulting primes, notably Research Triangle Institute (for Medicare risk adjustment model research under the Inflation Reduction Act, December 2023), the National Opinion Research Center (for IRA Medicare negotiation and rebate provisions implementation, December 2023), and Carahsoft Technology Corp (for analytic support for ASPE reports, February 2026), providing data access and clinical reference materials under those primes.

SCI-reported invoiced revenue on federal service contracts totaled $1.1 million across fiscal years 2022–2024, with $280 thousand in FY2023 and $837 thousand in FY2024. The SCI dataset records zero FTEs across all fiscal years, reflecting the fact that Merative's federal work is predominantly license and data-access delivery with minimal labor content — the vendor self-performed all SCI-reportable labor with zero subcontractor engagement. Government-paid hourly rates derived from SCI show a wide spectrum: the median rate ran $3,409 per hour, with outliers rising to $36,143 per hour in high-value analytical support tasks, reflecting the premium pricing of proprietary healthcare research databases and clinical decision support. Activity has remained episodic, with twelve awards in calendar 2023, four in 2024, four in 2025, and two in 2026, indicating transactional, renewal-driven revenue rather than sustained program growth.